Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
13,960
Value
$798.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,960$798.8K<0.1%−2,349−14.4%ReducedHolders
Q1 202616,309$921.3K<0.1%+132+0.8%AddedHolders
Q4 202516,177$961.4K<0.1%+1,170+7.8%AddedHolders
Q3 202515,007$812.8K<0.1%−659−4.2%ReducedHolders
Q2 202515,666$861.2K<0.1%−1,060−6.3%ReducedHolders
Q1 202516,726$1.18M<0.1%−1,218−6.8%ReducedHolders
Q4 202417,944$1.18M<0.1%−1,605−8.2%ReducedHolders
Q3 202419,549$1.37M<0.1%−1,128−5.5%ReducedHolders
Q2 202420,677$1.70M<0.1%+7,456+56.4%AddedHolders
Q1 202413,221$1.15M<0.1%+1,185+9.8%AddedHolders
Q4 202312,036$1.16M<0.1%−266−2.2%ReducedHolders
Q3 202312,302$1.09M<0.1%+157+1.3%AddedHolders
Q2 202312,145$1.05M<0.1%−787−6.1%ReducedHolders
Q1 202312,932$1.26M<0.1%−5,258−28.9%ReducedHolders
Q4 202218,190$1.88M<0.1%−366−2.0%ReducedHolders
Q3 202218,556$1.57M<0.1%+1,119+6.4%AddedHolders
Q2 202217,437$1.45M<0.1%−5,807−25.0%ReducedHolders
Q1 202223,244$1.79M<0.1%−7,226−23.7%ReducedHolders
Q4 202130,470$2.69M<0.1%−13,044−30.0%ReducedHolders
Q3 202143,514$3.36M<0.1%+4,065+10.3%AddedHolders
Q2 202139,449$3.29M<0.1%+10,866+38.0%AddedHolders
Q1 202128,583$2.16M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.